Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk

Like
Comment
Favorite

Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk

Dow Jones09-25

0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. "Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth," Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

September 24, 2025 22:02 ET (02:02 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2570707053?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570707053","market":"other","top_or_hot":-1,"title":"Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 24, 2025 22:02 ET (02:02 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEbos Gets Bull as Earnings Base Nears Reset -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-09-25 10:02</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 24, 2025 22:02 ET (02:02 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK8046","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2570707053","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570707053","pubTimestamp":1758765720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK8046":"保健护理产品经销商","EBO.AU":"EBOS GROUP LIMITED","EBO.NZ":"Ebos Group Limited Ordinary Shares","BK7103":"保健护理产品经销商"},"translate_title":"随着盈利基础接近重置，Ebos看涨——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBO.NZ":0.9,"EBO.AU":0.9},"content_text":"0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 24, 2025 22:02 ET (02:02 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}